<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="5010">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03041714</url>
  </required_header>
  <id_info>
    <org_study_id>170053</org_study_id>
    <secondary_id>17-N-0053</secondary_id>
    <nct_id>NCT03041714</nct_id>
  </id_info>
  <brief_title>Neurophysiologic Study of Patient With Essential Tremor and Dystonic Tremor</brief_title>
  <official_title>Neurophysiologic Study of Patients With Essential Tremor and Dystonic Tremor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      Background:

      Essential tremor is when a person has tremor, but no other neurological symptoms. Dystonic
      tremor is when a person also has dystonia. Dystonia is a condition in which muscle
      contraction causes changes in posture. Researchers do not fully know what areas of the brain
      cause these tremors, or how the types differ. They also do not know what tests can identify
      the differences.

      Objective:

      To look at differences between essential tremor and dystonic tremor.

      Eligibility:

      People ages 18 and older with or without tremor

      Design:

      Participants will be screened with medical history, physical exam, and urine tests. Those
      with tremor will complete questionnaires about how tremor affects them.

      The screening and study visits can be done on the same day or on separate days.

      Participants will have 1 or 2 study visits. These include magnetic resonance imaging (MRI)
      and tremor testing.

      For MRI, participants will lie on a table that slides in and out of a cylinder that takes
      pictures. Sensors on the skin measure breathing, heart rate, and muscle activity. This takes
      about 2 hours.

      Tremor testing will include transcranial magnetic stimulation (TMS), electrical stimulation
      of the fingers, doing a movement task, and recording of tremor movements. For TMS, two wire
      coils will be held on the scalp and a brief magnetic field will be produced. A brief
      electrical current will pass through the coils. For the other tests, small sticky pad
      electrodes will be put on the skin. Participants will move their hand when they hear a
      sound. They will get weak electrical shocks to their fingers. These tests will take 3-4
      hours.

      Participants can take part in either or both parts of the study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:

      &lt;TAB&gt;

      To explore a neurophysiological difference between patients with essential tremor (ET) and
      dystonic tremor (DT).

      Sample Size and Population:

      &lt;TAB&gt;

      We plan to recruit 26 healthy volunteers (HVs), 26 patients with ET, 26 patients with
      dystonic tremor from the Movement Disorders and Botulinum Toxin (BoNT) clinics of HMCS. The
      dystonic tremor group will be divided into 2 subgroups: pure dystonic tremor (pDT), patients
      who have dystonia and tremor in the same limb, tremor associated with dystonia (TAWD),
      patients who have isolated tremor with dystonia elsewhere. We plan to enroll 13 patients
      with pDT and 13 with TAWD. We plan to recruit a total of 20 participants including patients
      with ET, DT and HVs if the use of data from protocol 10-N-0009 is permitted. All
      neurophysiologic results will be compared between patients and HVs.

      Design:

      Subjects will come to NIH for at least one study visit. All subjects will undergo a
      screening visit including taking a medical history and physical examination. Then the
      patients will be scored clinically for tremor in both ET and DT and dystonia only for DT.
      All subjects will have a series of transcranial magnetic stimulation (TMS) studies.
      TMS-induced electromyographic (EMG) activity of hand and forearm muscles will be recorded as
      motor evoked potentials (MEPs). Pyramidal threshold will be determined by inion stimulation.
      Then, paired-pulse stimulation at the cerebellum followed by the motor cortex will be
      performed at rest and at tonic activation of the hand muscle. Only patients will have
      recordings of tremor at rest, postural holding, and with action and specific tasks such as
      writing by using accelerometry and EMG. Additionally, a single TMS will be delivered to the
      motor cortex or cerebellum while the patients elicit their tremor in order to explore the
      effect of TMS on tremor. All subjects (both HVs and ET, DT) will be tested for their
      threshold to discriminate somatosensory stimulation and for their performance of quick
      ballistic movements. All subjects will also undergo a magnetic resonance imaging (MRI) study
      which includes structural MRI, resting state functional MRI (rsfMRI), diffusion tensor
      imaging (DTI), MR spectroscopy. The subjects can either undergo the MRI study on the same
      visit as the other parts of experiment or do it separately.

      Outcome measurements:

      The various neurophysiological results include the data from the TMS experiment, tremor
      analysis, threshold of temporal discrimination, ballistic movement and MRI experiment. These
      results will be compared between HVs and patients group.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 27, 2017</start_date>
  <completion_date type="Anticipated">October 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The various neurophysiological results including the data from TMS experiment, tremor analysis, threshold of temporal discrimination, ballistic movement and MRI experiment. These results will be compared between HVs and patients group.</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Essential Tremor</condition>
  <condition>Cervical Dystonia</condition>
  <condition>Focal Dystonia</condition>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:

          -  Must be 18 years or older

          -  Fulfill the diagnostic criteria of essential tremor, pure dystonic tremor and tremor
             associated dystonia, as defined by the Consensus Statement of the Movement Disorder
             Society on Tremor, 1998. We will recruit patients displaying hand tremors in each
             group as the follows:

               -  Hand tremor patients in ET group.

               -  Dystonic hand tremor patients in pDT group.

               -  Cervical dystonia (CD) patients or spasmodic dysphonia and hand tremor without
                  clinical evidence of hand dystonia in TAWD group.

          -  For HVs only: absence of dystonia or other neurological disorder with any effect on
             the motor or sensory systems.

          -  Ability to give informed consent.

          -  Ability to comply with all study procedures, based on the judgment by the
             investigator(s).

          -  Agree to not drink caffeine or alcohol for 48 hours before participating in the
             protocol.

        EXCLUSION CRITERIA:

        Either of the following will exclude patients from the study:

          -  Secondary forms of dystonia and tremor, including tardive dyskinesia.

          -  Botulinum toxin treatment &lt; 3 months prior to visit.

        Any of the following will exclude both patients and healthy controls from the study:

          -  Employees and/or staff of NINDS

          -  Has used illegal drugs within the past 6 months based on history. The intent is to
             exclude those with drug use that may affect study results. Participants who appear to
             be intoxicated at the time of testing will be rescheduled.

          -  Has more than 7 alcoholic drinks a week in the case of a woman and 14 alcoholic
             drinks a week in the case of a man.

          -  Abnormal findings on neurologic exam (other than tremor and dystonia in patient
             group)

          -  Has had a brain tumor, a stroke, head trauma, epilepsy or a history of seizures.

          -  Has major depression or any major mental disorders (axis I disorders)

          -  Has a neurologic disorder other than tremor or dystonia

          -  Has had a head injury where there was a loss of consciousness for more than a few
             seconds.

          -  Has metal in the body, such as a cardiac pacemaker, brain stimulator, shrapnel,
             surgical metal, clips in the brain, cochlear implants, or metal fragments in the eye,

          -  Pregnancy and lactation

          -  For patients who are currently taking primidone, anticholinergics or benzodiazepines.

          -  For MRI scanning, unable to lie flat on the back for the expect length of the study
             up to 3 hours.

          -  For MRI scanning, uncomfortable being in a small space for up to 3 hours.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Hallett, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute of Neurological Disorders and Stroke (NINDS)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elaine P Considine, R.N.</last_name>
    <phone>(301) 435-8518</phone>
    <email>considinee@ninds.nih.gov</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL)</last_name>
      <phone>800-411-1222</phone>
      <phone_ext>TTY8664111010</phone_ext>
      <email>prpl@mail.cc.nih.gov</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_2017-N-0053.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <reference>
    <citation>Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord. 1998;13 Suppl 3:2-23. Review.</citation>
    <PMID>9827589</PMID>
  </reference>
  <reference>
    <citation>Ni Z, Pinto AD, Lang AE, Chen R. Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann Neurol. 2010 Dec;68(6):816-24. doi: 10.1002/ana.22221.</citation>
    <PMID>21194152</PMID>
  </reference>
  <reference>
    <citation>Pascual-Leone A, Valls-Sol√© J, Toro C, Wassermann EM, Hallett M. Resetting of essential tremor and postural tremor in Parkinson's disease with transcranial magnetic stimulation. Muscle Nerve. 1994 Jul;17(7):800-7.</citation>
    <PMID>8008009</PMID>
  </reference>
  <verification_date>January 30, 2017</verification_date>
  <lastchanged_date>February 2, 2017</lastchanged_date>
  <firstreceived_date>February 2, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Essential Tremor</keyword>
  <keyword>Cervical Dystonia</keyword>
  <keyword>Hand Dystonia</keyword>
  <keyword>Neurophysiology</keyword>
  <keyword>Dystonic Tremor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dystonia</mesh_term>
    <mesh_term>Dystonic Disorders</mesh_term>
    <mesh_term>Tremor</mesh_term>
    <mesh_term>Essential Tremor</mesh_term>
    <mesh_term>Torticollis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
